Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023 2023-10-16 21:10
Hong Kong Breast Cancer Foundation - "Pink Walk 2023" Charity Walk Concluded Successfully 2023-10-16 21:01
TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment 2023-10-16 21:00
I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023 2023-10-16 20:00
SeekIn Presents New Validation Studies of OncoSeek Multi-cancer Early Detection test at Early Detection of Cancer Conference in London 2023-10-16 20:00
Abbisko presented two preclinical research results at the 35th International Molecular Targets and Cancer Treatment Conference (EORTC-NCI-AACR) 2023-10-16 18:20
Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia's In-Vitro Diagnostics Industry 2023-10-16 15:29
CANbridge Announces Full Enrollment Reached in the Core Part of The CAN103 Phase 2 Trial for Gaucher Disease in China 2023-10-16 13:38
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL 2023-10-16 09:23
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis 2023-10-16 07:48
UEG Week 2023: Babies with a low birthweight four times more likely to develop fatty liver disease in later life 2023-10-16 06:01
HEALTHSCOPE : AI ENABLES PATIENT EMOTIONS TO BE ANALYSED IMPROVING HOSPITAL EXPERIENCE. 2023-10-16 04:00
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement 2023-10-13 23:26
Offering broader access to sustainable and scalable pharma-grade saponin adjuvants 2023-10-13 21:47
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston 2023-10-13 20:00
Inmagene Doses First Patient in Phase 2a Trial of IMG-007, an Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Alopecia Areata 2023-10-13 20:00
World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide 2023-10-13 15:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023-10-13 09:00
GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS 2023-10-13 09:00
Global Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Treatment-Naïve Patients with CLL/SLL Approved by the China CDE 2023-10-13 08:22
1 139 140 141 142 143 964